CD19 and acute lymphoblastic leukemia: Previous research attested that the alteration in SRSF3 expression in B-acute lymphoblastic leukemia (B-ALL) cells would influence the splicing process of CD19, and in return it could lead to the impaired recognition of anti-CD19 chimeric antigen receptor (CAR) in T-cells [65].